102 related articles for article (PubMed ID: 6284464)
1. [Anti-complement immunoperoxidase technique in the determination of EBNA antibody level in patients with nasopharyngeal carcinoma (author's transl)].
Liu YX
Zhonghua Zhong Liu Za Zhi; 1982 Feb; 4(1):20-2. PubMed ID: 6284464
[No Abstract] [Full Text] [Related]
2. [Application of anticomplement immunoenzymatic method for the detection of EBNA in carcinoma cells and normal epithelial cells from nasopharynx (author's transl)].
Zeng Y; Pi GH; Zhang Q; Shen SJ; Zhao ML; Ma JL; Dong HJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1980 Dec; 2(4):220-3. PubMed ID: 6273001
[No Abstract] [Full Text] [Related]
3. [Detection of EB virus-specific IgA antibody from patients with nasopharyngeal carcinoma by immunoenzymic method (author's transl)].
Liu YX; Zeng Y; Dong WP; Cao GR
Zhonghua Zhong Liu Za Zhi; 1979; 1(1):8-12. PubMed ID: 233233
[No Abstract] [Full Text] [Related]
4. [Detection of early NPC from VCA/IgA antibody positive individuals with anticomplement immunoenzymatic method].
Zeng Y; Shen SJ; Deng H; Ma JL; Zhang Q; Zhu JS; Cheng JR
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Aug; 4(4):254-5. PubMed ID: 6295651
[No Abstract] [Full Text] [Related]
5. Development of an anticomplement immunoenzyme test for detection of EB virus nuclear antigen (EBNA) and antibody to EBNA.
Guohua P; Yi Z; Winping Z; Qin Z
J Immunol Methods; 1981; 44(1):73-8. PubMed ID: 6265562
[TBL] [Abstract][Full Text] [Related]
6. [The diagnosis of nasopharyngeal carcinoma (author's transl)].
Arnold W; Nakazima A; Wang YB; Vosteen KH; Brunner H; Göbel U
HNO; 1980 Aug; 28(8):247-60. PubMed ID: 6254933
[TBL] [Abstract][Full Text] [Related]
7. [Detection of IgA serum antibodies to EB virus VCA in patients having survived nasopharyngeal cancer for over 15 years (author's transl)].
Tang ZH
Zhonghua Yi Xue Za Zhi; 1982 Mar; 62(3):167-9. PubMed ID: 6286059
[No Abstract] [Full Text] [Related]
8. [Detection of antibodies against Epstein's and Barr's virus in patients with carcinoma of the nasopharynx in the CSSR (author's transl)].
Síbl O; Vonka V; Vlcková I; Závadová H
Cas Lek Cesk; 1974 Oct; 113(42):1284-7. PubMed ID: 4370878
[No Abstract] [Full Text] [Related]
9. [The cytotoxic effect of lymphocytes from patients with nasopharyngeal cancer (NPC) against a NPC epitheloid cell line (author's transl)].
Lin YC; Chao WP; Liu CR; Hu RL; Zeng Y
Zhonghua Zhong Liu Za Zhi; 1981 Feb; 3(1):1-4. PubMed ID: 6273085
[No Abstract] [Full Text] [Related]
10. [Detection of EB virus nuclear antigen (EBNA) by anticomplement immunoenzymatic method (author's transl)].
Zeng Y; Pi GH; Zhao WP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1980 Jun; 2(2):134-5. PubMed ID: 6253093
[No Abstract] [Full Text] [Related]
11. [Carcinomas of the nasopharynx. Relationship between histological type and anti-Epstein-Barr virus serology (author's transl)].
Micheau C; de The G; Orofiamma B; Schwaab G; Brugere J; Tursz T; Sancho-Garnier H; Cachin Y
Nouv Presse Med; 1980 Jan; 9(1):21-4. PubMed ID: 6243770
[TBL] [Abstract][Full Text] [Related]
12. Studies on antibody surveillance to EB virus-induced antigen in patients with sarcoidosis and nasopharyngeal carcinoma by indirect immunofluorescence.
Naito M; Akiyama Y; Kato S; Tachibana T; Sakai T
Biken J; 1973 Dec; 16(4):141-8. PubMed ID: 4363326
[No Abstract] [Full Text] [Related]
13. [Studies on the relationship between clinical course and antibody titer to Epstein-Barr virus in nasopharyngeal carcinoma (author's transl)].
Inuyama Y; Saito S; Ozu R; Horiuchi M; Asaoka K
Nihon Jibiinkoka Gakkai Kaiho; 1975 Dec; 78(12):1237-43. PubMed ID: 176338
[No Abstract] [Full Text] [Related]
14. [Serological mass survey of nasopharyngeal carcinoma (author's transl)].
Zeng Y; Liu YX; Wei JN; Zhu JS; Cai SL; Wang PZ; Zhong JM; Li RC; Pan WJ; Li EJ; Tan BF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1979 Dec; 1(2):123-6. PubMed ID: 233641
[No Abstract] [Full Text] [Related]
15. [Detection of intracellular herpes virus antigens by immuno-enzyme procedures].
Kurstak E; Kurstak C; Morisset R
Dev Biol Stand; 1982; 52():187-91. PubMed ID: 6299829
[TBL] [Abstract][Full Text] [Related]
16. [A modified 131 I immuno-autoradiographic method for detection of serum EB virus VCA-IgA antibody in nasopharyngeal carcinoma].
Shang M
Zhonghua Zhong Liu Za Zhi; 1982 Nov; 4(4):262-4. PubMed ID: 6299669
[No Abstract] [Full Text] [Related]
17. Histological types of nasopharyngeal carcinoma as compared to EBV serology.
Krueger GR; Kottaridis SD; Wolf H; Ablashi DV; Sesterhenn K; Bertram G
Anticancer Res; 1981; 1(4):187-94. PubMed ID: 6285799
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between changes of 3 types of anti-EB virus antibodies in the serum of patients with nasopharyngeal cancer and their clinical courses].
Terayama Y; Ueno M; Kamata N; Jinnai I; Sasaki Y
Nihon Jibiinkoka Gakkai Kaiho; 1972 Oct; 75(10):1079-80. PubMed ID: 4120228
[No Abstract] [Full Text] [Related]
19. Seroepidemiological studies on carcinoma of the nasopharynx.
Lin TM; Yang CS; Chiou JF; Tu SM; Lin CC; Liu CH; Chen KP; Ito Y; Kawamura A; Hirayama T
Cancer Res; 1973 Nov; 33(11):2603-8. PubMed ID: 4355974
[No Abstract] [Full Text] [Related]
20. Auto-antibodies in the sera of patients with nasopharyngeal carcinoma.
Yoshida TO; Yasuda-Yasaki Y; Utsumi KR
IARC Sci Publ (1971); 1975; (11 Pt 2):259-73. PubMed ID: 191369
[No Abstract] [Full Text] [Related]
[Next] [New Search]
